Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis
{{output}}
Importance: Immune checkpoint inhibitors (ICIs) have become the standard treatment for advanced non-small cell lung cancer (NSCLC). However, their prognostic role in NSCLC patients remains controversial. Hypertension (HTN) is an ... ...
